The aims of the present study were to investigate the relationship between severe hypoglycaemia and autonomic dysfunction in diabetic children, and to assess the glycaemic response to an insulin infusion test. In a one year period, 12 of 69 diabetic patients (17%) experienced at least one severe episode of hypoglycaemia, defined as an event which required outside assistance. AU patients underwent five cardiovascular autonomic tests. Seven of the hypoglycaemic patients showed three or more abnormal autonomic tests. Among the 57 non-hypoglycaemic diabetics, there was no patient with three or more abnormal tests. In hypoglycaemic diabetics with and without autonomic dysfunction, and in eight healthy age matched subjects an insulin infusion test was performed. A pronounced blood glucose decline and a subnormal increase in heart rate during insulin infusion were obtained in patients with autonomic dysfunction. Thus, severe hypoglycaemia may be due to impaired defence mechanisms against blood glucose decline in diabetic children with autonomic dysfunction.
Accepted 21 June 1991 Hypoglycaemia represents a constant risk for all patients with insulin dependent diabetes mellitus.1-3 Until recently, hypoglycaemia was considered as an acute event of inadequate diabetes management with no long term consequences. However, recent studies report that irreversible brain damage or intellectual impairment may be the consequence of severe hypoglycaemia. 4 Currently available data indicate that severe hypoglycaemic episodes not infrequently accompany conventional insulin treatment and are even more frequent in patients receiving intensified insulin regimens.' 7 8 Nevertheless, little information is available concerning such episodes in children with diabetes.
There are a number of well established reasons which may explain why diabetic patients run into severe hypoglycaemic episodes. Poor compliance with injection technique, inappropriate insulin dosing with respect to meals and physical activity, and a recent change of insulin dose are factors known to precipitate hypoglycaemia9 10; however, one study reported that no cause could be defined in over one third of patients." One assumption is that autonomic nervous system dysfunction may be responsible for increased risk of severe hypoglycaemia, as autonomic activation plays an important role in defence mechanisms against hypoglycaemia.12-6 In this respect, the importance of disturbed autonomic function is not yet clear in childhood diabetes.
The aims of our present study were to investigate the relationship between severe hypoglycaemia and autonomic nervous system dysfunction in diabetic children treated conventionally with insulin and studied prospectively, and to assess the glycaemic response to an insulin infusion test. With this purpose, we included only those episodes of severe hypoglycaemia that caused loss of consciousness or convulsions and required outside assistance.
Patients and methods Sixty nine children with insulin dependent diabetes mellitus who had been treated conventionally with insulin (two injections per day) since the onset of disease were considered for inclusion in this study. This represented 58% of the diabetic children seen in our clinic during the study period. All patients were receiving highly purified porcine insulin (Actrapid MC and Monotard MC, Novo-Nordisk) but no other medications. All were healthy except for diabetes, having negligible basal C peptide secretion (fasting C peptide concentration <0 1 nmol/l). The Five cardiovascular tests were performed at the start of the prospective study, and one year later.
Each diabetic child was examined in the lying position for the mean resting heart rate for a period of one minute, and for beat to beat variation during five maximal inspirations and expirations, for increase in heart rate and fall in systolic blood pressure during one minute standing after the lying position, and for rise in diastolic blood pressure after a one minute sus- To maintain an overnight normoglycaemia in the diabetic subjects, variable rate intravenous infusions of insulin and glucose were started at 24.00 h. The rates were adjusted according to frequent blood glucose measurements. At 07.00 h a constant rate intravenous insulin infusion was started (0-02 U/kg/h, Actrapid HM, NovoNordisk) and continued for three hours. Subjects were asked before the study to report immediately any symptoms that they thought might be due to hypoglycaemia. During the three hour constant rate insulin infusion period, capillary blood glucose concentration, heart rate, and blood pressure were determined at 30 minute intervals, and the skin was examined for signs of sweating. Venous blood samples were taken at 60 minute intervals for measurement of free insulin and blood glucose. All subjects gave their informed consent to the study which was approved by the local ethical committee.
ANALYTIC METHODS
Capillary blood glucose concentrations were determined by means of a glucose reflectance meter (Ames Company, Division Miles Laboratories), and venous glucose concentrations were measured by the glucose oxidase method.
Serum fructosamine was measured by the Roche fructosamine kit. The mean (SD) for non-diabetic children was 2-0 (0-3) mmol/l. Fasting serum C peptide concentration was determined by the Mallincrodt kit (RIA-mat C peptide). The normal fasting value is 0*17-0-99 nmol/l. Plasma for free insulin was treated with polyethylene glycol immediately after separation to precipitate antibody-bound insulin. The supernatant was then assayed within four weeks with a double antibody radioimmunoassay. The sensitivity of the assay is 0 3 mU/l with a coefficient of variation of 0-04. insulin profiles in the two groups of patients and in the healthy control group (group C) were compared. As shown in the figure, blood glucose concentrations were similar in the three groups of children before insulin infusion test. Glucose profiles during the insulin infusion test were similar in rrouns B and C whereas erouD p<OOl). Group C had lower plasma free insulin concentrations than groups A and B before insulin infusion test (8 (3) v 20 (4) and 23 (5) mU/l, p<0 02). The steady state plasma free insulin concentrations were similar in the three groups. The metabolic clearance rates for insulin in groups A (559 (80) ml/m2/min), B (542 (73) ml/m2/min) and C (596 (67) ml/m2/min) were not statistically different. The increase in heart rate during insulin infusion test was similar in groups B and C, whereas group A showed a subnormal heart rate increment (5 (6) v 24 (7)/ min, p<00l and 30 (5)/min, p<OIOOl). Significant change in blood pressure and increased sweating were not observed in any group studied. Hypoglycaemic symptoms, necessitating cessation of the insulin infusion, did not develop in any subject.
_ i c_ _ _.,_&& __,5 *U Discussion )wed a more pronounced glucose decline. In this study about 17% of diabetic children nean blood glucose concentration at glucose treated alywth insulin showdoe was lower in group A than in groups B treated conventionally with insulin showed one (2-7 (0-3) v 3-8 (0-4) and 3-9 (0-4) mmolIl, or more severe hypoglycaemic episodes in a single year. This hypoglycaemic group had had diabetes for longer and had greater cardiovas-IV insulin infusion (0-02 U/kg/h) cular autonomic dysfunction than the nonhypoglycaemic group. Moreover, there was a relationship between autonomic dysfunction and abnormal glycaemic and heart rate responses to the insulin infusion test in hypoglycaemic patients. 
